Laboratory Acquired Infection with Recombinant Vaccinia Virus Containing an Immunomodulating Construct
- 1 March 2003
- journal article
- case report
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (3) , 356-358
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Critical evaluation of smallpox vaccination for laboratory workersOccupational and Environmental Medicine, 2002
- Primary Induction of Human CD8+Cytotoxic T Lymphocytes and Interferon‐γ–Producing T Cells after Smallpox VaccinationThe Journal of Infectious Diseases, 2002
- Cidofovir in the treatment of poxvirus infectionsAntiviral Research, 2002
- Smallpox Vaccinations: How Much Protection Remains?Science, 2001
- Cytohesin‐1 regulates β‐2 integrin‐mediated adhesion through both ARF‐GEF function and interaction with LFA‐1The EMBO Journal, 2000
- Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.Proceedings of the National Academy of Sciences, 1996
- A monoclonal blocking-ELISA for detection of orthopoxvirus antibodies in feline seraVeterinary Microbiology, 1996
- αLβ2 Integrin/LFA-1 Binding to ICAM-1 Induced by Cytohesin-1, a Cytoplasmic Regulatory MoleculeCell, 1996
- Sequence alterations within and downstream of the A-type inclusion protein genes allow differentiation of Orthopoxvirus species by polymerase chain reactionJournal of General Virology, 1994
- Accidental infection of laboratory worker with recombinant vaccinia virusThe Lancet, 1991